<SEC-DOCUMENT>0001564590-19-032608.txt : 20190820
<SEC-HEADER>0001564590-19-032608.hdr.sgml : 20190820
<ACCEPTANCE-DATETIME>20190820083556
ACCESSION NUMBER:		0001564590-19-032608
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20190820
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190820
DATE AS OF CHANGE:		20190820

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HERON THERAPEUTICS, INC. /DE/
		CENTRAL INDEX KEY:			0000818033
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				942875566
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33221
		FILM NUMBER:		191037898

	BUSINESS ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582514400

	MAIL ADDRESS:	
		STREET 1:		4242 CAMPUS POINT COURT, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AP PHARMA INC /DE/
		DATE OF NAME CHANGE:	20010511

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED POLYMER SYSTEMS INC /DE/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hrtx-8k_20190820.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2019-08-20T05:12:39.0550261+00:00 -->
<!-- Version            : 3.6.7150.26138 -->
<!-- Package ID         : 7a76157b86c7423594c481756eb6c942 -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:hrtx="http://www.herontx.com/20190820" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
hrtx-8k_20190820.htm
</title>
</head>
<!-- NG Converter v5.0.19114.147 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000818033_20190820_20190820">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0000818033_20190820_20190820">HERON THERAPEUTICS, INC. /DE/</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0000818033_20190820_20190820">0000818033</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="hrtx-20190820.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000818033_20190820_20190820">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000818033</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2019-08-20</xbrli:startDate>
					<xbrli:endDate>2019-08-20</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;text-indent:0%;font-size:3pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000818033_20190820_20190820">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000818033_20190820_20190820" format="ixt:datemonthdayyearen">August 20, 2019</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc. </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:30.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:37.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000818033_20190820_20190820">001-33221</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:29.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000818033_20190820_20190820">94-2875566</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:30.58%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:37.24%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:29.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:56.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0000818033_20190820_20190820">4242 Campus Point Court</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0000818033_20190820_20190820">Suite 200</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0000818033_20190820_20190820">San Diego</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0000818033_20190820_20190820">CA</ix:nonNumeric></p></td>
<td valign="bottom" style="width:0.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0000818033_20190820_20190820">92121</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:56.18%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices)</p></td>
<td valign="bottom" style="width:0.2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:43.62%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code <ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0000818033_20190820_20190820">(858)</ix:nonNumeric> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0000818033_20190820_20190820">251-4400</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N/A </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:3pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:38.25%;margin-right:38.22%;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Emoji;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:39.92%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:22.6%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol(s)</p></td>
<td valign="bottom" style="width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:34.84%;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="width:39.92%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0000818033_20190820_20190820">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:22.6%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0000818033_20190820_20190820">HRTX</ix:nonNumeric></p></td>
<td valign="bottom" style="width:1.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:34.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">The <ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;<span style="font-family:Segoe UI Emoji;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000818033_20190820_20190820" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Segoe UI Emoji;">&#9744;</span> </p>
<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Double 2.25pt #000000;padding-bottom:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 7.01 Regulation FD Disclosure.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;" id="part_1_2_2">On August 20, 2019, Heron Therapeutics, Inc. issued a press release announcing that the results from the pivotal Phase 3 EPOCH 2 herniorrhaphy study of the investigational agent HTX-011 have been published online by the <span style="font-style:italic;">Hernia</span> journal, as described in the press release furnished herewith as Exhibit 99.1.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01 Financial Statements and Exhibits. </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:10%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="bottom" style="width:89%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="bottom" style="width:10%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
<td valign="bottom" style="width:89%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:10%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:89%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="hrtx-ex991_48.htm"><span style="text-decoration:underline;">Press Release, dated August 20, 2019</span></a></p></td>
</tr>
<tr>
<td valign="top" style="width:10%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:89%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics, Inc.</p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
<td style="border:none;padding:0;"></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: August 20, 2019</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:49%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ David Szekeres</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Szekeres</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Vice President, General Counsel,<br />Business Development and Corporate Secretary</p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="width:49%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>hrtx-ex991_48.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
hrtx-ex991_48.htm
</title>
</head>
<!-- NG Converter v5.0.19114.147 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Exhibit 99.1</font></p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g2pgxexemedg000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;"><a name="_Hlk480203125"></a>&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Arial;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SAN DIEGO, Calif. &#8211; (PR NEWSWIRE) &#8211; August 20, 2019 -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the results from EPOCH 2, a Phase 3 study of the investigational agent HTX-011 in open inguinal hernia repair surgery with mesh, have been published in the journal, <font style="font-style:italic;">Hernia</font>, in an article entitled &#8220;HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study.&#8221; HTX-011 achieved all primary and key secondary endpoints in EPOCH 2, demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications following surgery and an increase in the proportion of patients who were opioid-free. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HTX-011 is a dual-acting, fixed-dose combination of the local anesthetic bupivacaine with a low dose of the nonsteroidal anti-inflammatory drug meloxicam. It&#160;is the first and only extended-release local anesthetic to demonstrate in Phase 3 studies significantly reduced pain and opioid use through 72 hours compared to bupivacaine solution, the current standard-of-care local anesthetic for postoperative pain control. Heron has completed two pivotal Phase 3 studies of HTX-011: EPOCH 1 in bunionectomy, which is a study of a bony tissue surgical model, and EPOCH 2 in hernia repair, which is a study of a soft tissue surgical model.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In EPOCH 2, all primary and key secondary endpoints were achieved. HTX-011 provided superior and sustained pain reduction compared to placebo and bupivacaine solution through the critical 72-hour postoperative window, when pain is often most severe. Significant reductions in pain occurred both early (in the first 8 through 24 hours) and were sustained from 24 through 72 hours. In addition to reductions in average pain intensity scores, HTX-011 significantly reduced the proportion of patients experiencing severe pain through 72 hours compared to placebo and bupivacaine solution. Significant reductions in pain were consistent with the significant decrease in total opioid consumption and the significant increase in opioid-free patients receiving HTX-011, both through 72 hours and as compared to placebo and bupivacaine solution. HTX-011 was well tolerated, with a safety profile comparable to placebo and bupivacaine solution.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Despite the many risks of opioid use,<font style="color:#000000;"> </font>most patients undergoing hernia repair surgery are prescribed opioids after surgery,&#8221; said&#160;Sonia Ramamoorthy, M.D., Chief of Colorectal Surgery at<font style="color:#000000;"> </font>UC San Diego Health. &#8220;These data suggest HTX-011 can significantly reduce postoperative pain, including severe pain, and help patients reduce and even avoid the need for opioids. For the approximately 800,000 inguinal hernia repairs done in the United States each year, exposing fewer patients to opioids and discharging the majority of them without opioids could have a positive impact on the country&#8217;s high rate of opioid dependency.&#8221; </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-size:11pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<font style="font-style:italic;"> Hernia</font> article can be found <font style="text-decoration:underline;color:#000000;">here</font>.</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g2pgxexemedg000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-weight:bold;color:#1E1E1E;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About EPOCH </font><font style="font-weight:bold;color:#1E1E1E;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">2</font></p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">EPOCH 2 was a randomized, placebo- and active-controlled, double-blind, pivotal Phase 3 clinical study evaluating the efficacy and safety of locally administered HTX-011 at 300 mg/9 mg bupivacaine/meloxicam compared to placebo and the standard dose of bupivacaine solution (75 mg) for postoperative pain control following hernia repair surgery in 418 patients. All primary and key secondary endpoints were achieved:</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-family:Arial;">There was a 23% reduction in pain intensity as measured by the Area Under the Curve (AUC) 0&#8211;72 when comparing HTX-011 to placebo (p&lt;0.001).</font></p></td></tr></table></div>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;margin-left:7.76%;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-family:Arial;">There was a 21% reduction in pain intensity as measured by AUC 0&#8211;72 when comparing HTX-011 to the current standard-of-care, bupivacaine solution (p&lt;0.001).</font></p></td></tr></table></div>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-family:Arial;">Over 72 hours post-surgery, patients receiving HTX-011 consumed 38% less opioids than patients receiving placebo (p&lt;0.001) and 25% less opioids than patients receiving bupivacaine solution (p=0.024).</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.76%;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="Background-color:#FEFEFE;margin-top:0pt;margin-bottom:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-family:Arial;">51% of patients receiving HTX-011 required no opioid medication for 72 hours post-surgery compared to only 22% receiving placebo (p&lt;0.001) and 40% receiving bupivacaine solution (p=0.049). These results parallel the significantly reduced incidence of severe pain in patients receiving HTX-011 compared to both placebo (40% reduction; p&lt;0.001) and bupivacaine solution (19% reduction; p=0.037).</font></p></td></tr></table></div>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-family:Arial;">Among the HTX-011-treated patients who were opioid-free through 72 hours post-surgery, more than 84% remained opioid-free through day 28.</font></p></td></tr></table></div>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;">&nbsp;</p></td>
<td valign="top" style="width:3.88%;white-space:nowrap">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#1E1E1E;font-family:'Times New Roman';font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#x2022;</font></p></td>
<td valign="top">
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;color:#1E1E1E;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:11pt;"><font style="font-family:Arial;">HTX-011 was well tolerated, with a safety profile comparable to placebo and bupivacaine solution.</font></p></td></tr></table></div>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#1E1E1E;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About HTX-011 for Postoperative Pain </p>
<p style="Background-color:#FEFEFE;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HTX-011, which utilizes Heron's proprietary Biochronomer&#174; drug delivery technology, is an investigational, long-acting, extended-release formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam for the management of postoperative pain. By delivering sustained levels of both a potent anesthetic and a local anti-inflammatory agent directly to the site of tissue injury, HTX-011 was designed to deliver superior pain relief while reducing the need for systemically administered pain medications such as opioids, which carry the risk of harmful side effects, abuse and addiction. HTX-011 has been shown to reduce pain significantly better than placebo or bupivacaine solution in five diverse surgical models: hernia repair, abdominoplasty, bunionectomy, total knee arthroplasty and breast augmentation. HTX-011 was granted Fast Track designation from the U.S. Food and Drug Administration (FDA) in the fourth quarter of 2017 and Breakthrough Therapy designation in the second quarter of 2018. Heron submitted a New Drug Application (NDA) to the FDA for HTX-011 in October of 2018 and received Priority Review designation in December of 2018. A Complete Response Letter was received from the FDA regarding the NDA for HTX-011 on April 30, 2019 relating to chemistry, manufacturing and controls and non-clinical information. No issues related to clinical efficacy or safety were noted. A Marketing Authorisation Application (MAA) for HTX-011 was validated by the European Medicines Agency (EMA) in March 2019 for review under the Centralised Procedure.</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="g2pgxexemedg000001.jpg" title="" alt="" style="width:152px;height:59px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About Heron Therapeutics, Inc. </p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Heron Therapeutics<font style="color:#1E1E1E;">, Inc.&#160;is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer. For more information, visit&#160;</font><font style="color:#1D4095;text-decoration:underline;">www.herontx.com</font><font style="color:#1E1E1E;">.</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk479741885"></a>Forward-l<a name="_Hlk479741885"></a>ooking Statements </p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;color:#1E1E1E;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to, those associated with: whether the&#160;<font style="color:#000000;">FDA</font>&#160;approves the NDA for HTX-011; the timing of the commercial launch of HTX-011; the timing of the EMA Committtee for Medicinal Products for Human Use (CHMP) review process for HTX-011; whether the&#160;<font style="color:#000000;">European Commission</font>&#160;authorizes the MAA for HTX-011; and other risks and uncertainties identified in the Company's filings with the&#160;U.S. Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Arial;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations and Media Contact:</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;">&nbsp;</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Szekeres<br />Senior VP, General Counsel, Business Development&#160;and Corporate Secretary<br />Heron Therapeutics, Inc.</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dszekeres@herontx.com</p>
<p style="margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Arial;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">858-251-4447</p>
<p style="text-align:center;margin-bottom:0pt;line-height:14pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="text-align:right;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g2pgxexemedg000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g2pgxexemedg000001.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !A /<# 1$  A$! Q$!_\0
M'P !  (" P$! 0$           @)!PH$!08#"P(!_\0 5Q   00" @$ ! 8)
M#P<*!P  ! (#!08!!P ("1$2$Q05%ADA6-87(B,Q-W:6E]4*)#8X5E=9=WB4
ME;.TM=AA<71U@;:W&#(T.3I!0E&QPC6(D=37\/'_Q  = 0$  @(# 0$
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M.ID*H$NWCR8:ES<KTG/&5P]$:%;QM;@Q>1C$X3J18WKL?)LC,[7LV<TO<@I
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M1TV6-.RN2+T$BV3X>07+1,7*.1TC$+DH\(]<3,-,,2T8HP9LA4?*,#$%CLR
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M /VOI;^+]M_-M4[>6W8?CMV!5=+5OHJC4]G[B2NX:>/KXOJM%1 <FV"XHUG
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MTKZ^#Y>MMNG_ *_+&[DUK#UJH>E=5N@5CB9]#W)</F!YB.<EMLO.?L?6:O\
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M.B;WM0-MQF,TEK&0C[7L(V6RC/NH,V. 0['4<9U?JJ>/N!D5GW;UUQHDJ9[
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M,Y]@A]3]0L)]>(+PX/C#>&3'@%$LHSCUVVW$H7G*L9SS([<SRMQXXLBFNRL
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MW5G$*/)&9CT*93E(ZRDDO?<&7.9I&:SW>17]K-H5%IL.=:]^,=:\.$5VN$?
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>hrtx-20190820.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2019-08-19T19:52:19.6269946+00:00 -->
<!-- Version            : 3.6.7150.26138 -->
<!-- Package ID         : 7a76157b86c7423594c481756eb6c942 -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:hrtx="http://www.herontx.com/20190820" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.herontx.com/20190820" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" namespace="http://xbrl.sec.gov/country/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2019-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2019-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" namespace="http://fasb.org/srt/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd" namespace="http://fasb.org/srt-roles/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" namespace="http://fasb.org/srt-types/2019-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" namespace="http://fasb.org/us-gaap/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" namespace="http://fasb.org/us-roles/2019-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" namespace="http://fasb.org/us-types/2019-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.herontx.com/20190820/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hrtx-20190820_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hrtx-20190820_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hrtx-20190820_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2019-08-19T19:52:19.6269946+00:00 -->
<!-- Version            : 3.6.7150.26138 -->
<!-- Package ID         : 7a76157b86c7423594c481756eb6c942 -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hrtx-20190820_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2019-08-19T19:52:19.6269946+00:00 -->
<!-- Version            : 3.6.7150.26138 -->
<!-- Package ID         : 7a76157b86c7423594c481756eb6c942 -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.herontx.com/20190820/role/TemplateLink" xlink:href="hrtx-20190820.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hrtx-20190820.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>hrtx-8k_20190820_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hrtx-20190820.xsd" xlink:type="simple"/>
    <context id="C_0000818033_20190820_20190820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000818033</identifier>
        </entity>
        <period>
            <startDate>2019-08-20</startDate>
            <endDate>2019-08-20</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000818033_20190820_20190820" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="C_0000818033_20190820_20190820" id="F_000003">HERON THERAPEUTICS, INC. /DE/</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="C_0000818033_20190820_20190820" id="F_000004">0000818033</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0000818033_20190820_20190820" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000818033_20190820_20190820" id="F_000002">2019-08-20</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000818033_20190820_20190820" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000818033_20190820_20190820" id="F_000006">001-33221</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000818033_20190820_20190820" id="F_000008">94-2875566</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000818033_20190820_20190820" id="F_000009">4242 Campus Point Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0000818033_20190820_20190820" id="F_000010">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0000818033_20190820_20190820" id="F_000011">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000818033_20190820_20190820" id="F_000012">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000818033_20190820_20190820" id="F_000013">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000818033_20190820_20190820" id="F_000014">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000818033_20190820_20190820" id="F_000015">251-4400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000818033_20190820_20190820" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000818033_20190820_20190820" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000818033_20190820_20190820" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000818033_20190820_20190820" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000818033_20190820_20190820" id="F_000020">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000818033_20190820_20190820" id="F_000021">HRTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000818033_20190820_20190820" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000818033_20190820_20190820" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6643759744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 20, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 20,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HERON THERAPEUTICS, INC. /DE/<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000818033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-2875566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4242 Campus Point Court<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">251-4400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HRTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( 'M$%$\?(\\#P    !,"   +    7W)E;',O+G)E;'.MDD^+
MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V
M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F'
M.>RGGD7E2B.5^S3%":4A+<TXP)6E/S/WJVR;A5ND9T*YKCM+1[873T$7LF<;
M!I99-G\LCNVW<+ZT+/0:S>,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C
M-R."?S]PN -02P,$%     @ >T043R?HAPZ"    L0   !    !D;V-0<F]P
M<R]A<' N>&UL38Y-"\(P$$3_2NG=;BGH06) L$?!D_>0;FP@R8;-"OGYIH(?
MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MZP^_B[ ;C-W:?VQ\%I0M_+H+^0502P,$%     @ >T043YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M"H(I(BJXR0GT, V3CV%BV<>=3J"1*<@^@HEE'[<[@6ZF(/L()I9]W/($&KH
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M7PW_R?(+4$L! A0#%     @ >T043Q\CSP/     $P(   L
M ( !     %]R96QS+RYR96QS4$L! A0#%     @ >T043R?HAPZ"    L0
M !               ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" ![1!1/O<;_$.\    K @  $0              @ &9 0  9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " ![1!1/F5R<(Q &  "<)P  $P
M    @ &W @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( 'M$%$^8
MX#^8JP(  /D+   8              "  ?@(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " ![1!1/#5:=RWD"  !8!@  %
M    @ '9"P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4    " ![1!1/
MNJ$YBM<!   R!@  #0              @ &$#@  >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( 'M$%$\6;2-_0P$  #P"   /              "  880  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " ![1!1/_\ F"+T   "% @  &@
M            @ 'V$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " ![1!1/"X_8 R$!  !7!   $P              @ 'K$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "@ * ( "   ]%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hrtx-8k_20190820.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="hrtx-8k_20190820.htm">hrtx-8k_20190820.htm</File>
    <File>hrtx-20190820.xsd</File>
    <File>hrtx-20190820_lab.xml</File>
    <File>hrtx-20190820_pre.xml</File>
    <File>hrtx-ex991_48.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hrtx-8k_20190820.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "hrtx-8k_20190820.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hrtx-20190820_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hrtx-20190820_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hrtx-20190820.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hrtx",
   "nsuri": "http://www.herontx.com/20190820",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "hrtx-8k_20190820.htm",
      "contextRef": "C_0000818033_20190820_20190820",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "hrtx-8k_20190820.htm",
      "contextRef": "C_0000818033_20190820_20190820",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.herontx.com/20190820/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001564590-19-032608-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-19-032608-xbrl.zip
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M-1>]!:FQZ K9"+;KW#<($X^/0AJQ+D\];QY180EJ>TO$K^#$6^! 6698XA:
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M'4WV**M72MFC9<,#_8789ZT<=S1$ 2[\'&1[7L4U> -'?PN$L(!.@..^'WT
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M \.CU1_D0K!'RH7![),)5>"+QY=,4/)U"P"93MIZ,( 3,&\+]<K,N2A/*!<
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MSQ(F9MF?X74LF"FN')< @N!_^"M,D6A$Q8#[Q5Z@5#!JF*$Z2IZH(-0_>X&
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M(AG4)^><#8)5R+ 7DJ$-W:_B2@1CKC/S5J&E>?849]<TWK>O6RD;!W,<>"?
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M#QL8%H\I:FJO,H'5IN-<TL>15WCM%=YXA6<3:2,&A8R:+.)GX)[ ,QF9G(E
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MX3L*GK79;_B%/N$9C.<<WLD*4+'5[3:QP$MR+(,H,:V"[Z^II.#F&!D!5%_
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M.#(P7VQA8BYX;6Q02P$"% ,4    " ![1!1/AFQ;)@P%  "I+0  %0
M        @ %K#   :')T>"TR,#$Y,#@R,%]P<F4N>&UL4$L! A0#%     @
M>T043V*,R$E8$   88D  !0              ( !JA$  &AR='@M.&M?,C Q
M.3 X,C N:'1M4$L! A0#%     @ >T043UXZ1/F($0  X&   !$
M     ( !-"(  &AR='@M97@Y.3%?-#@N:'1M4$L%!@     %  4 1@$  .LS
$      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
